Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
Allocated share-based compensation expense | $ 27 | $ 686 | $ 394 | $ 2,443 |
Cost of Sales | ||||
Allocated share-based compensation expense | 43 | 133 | ||
Research and Development | ||||
Allocated share-based compensation expense | 11 | 119 | 120 | 440 |
Clinical and Regulatory | ||||
Allocated share-based compensation expense | 12 | 19 | 39 | 84 |
Selling and Marketing | ||||
Allocated share-based compensation expense | 118 | 41 | 379 | |
General and Administrative | ||||
Allocated share-based compensation expense | $ 4 | $ 387 | $ 194 | $ 1,407 |